Maternal and neonatal outcomes in pregnant women with gestational diabetes mellitus treated with diet, metformin or insulin
Keywords:
gestational diabetes, insulin, metformin, neonatal outcomes, pregnant womenAbstract
Background; Diabetes mellitus during pregnancy Around 7–10 percent of all pregnancies in the globe are affected with GDM. GDM is more common in pregnant women who are older & more fat. GDM raises the risk of pregnancy problems such as pregnancy-induced hypertension & poor neonatal outcome, as well as development of type two diabetes later in life (T2DM), Aim and objectives; to evaluate maternal & neonatal results in pregnant females with gestational diabetes mellitus handled with diet control, metformin or insulin, Subjects & methods; This was a prospective observational study; 120 patients were being selected from attendee of Obstetrics & Gynecology clinics of AL Hussein University Hospital, All patients were being subdivided into 3 groups, Result; Between 3 categories, there were substantial variances regarding postprandial glycaemia it was substntially lower in category 3 then category 1 with higher level in category 2, Conclusion; Metformin is helpful & safe in treating of GDM, as evidenced by fact that females with GDM who took metformin gained less weight & had better neonatal results than those who took diet or insulin.
Downloads
References
Adam S, Rheeder P. Screening for gestational diabetes mellitus in a South African population: prevalence, comparison of diagnostic criteria and the role of risk factors. S Afr Med J. 2017; 107:523– 7.
Thevarajah, A, & Simmons, D. Risk factors and outcomes for neonatal hypoglycaemia and neonatal hyperbilirubinaemia in pregnancies complicated by gestational diabetes mellitus: a single centre retrospective 3‐year review. Diabetic Medicine, 2019; 36(9), 11091117.
Rudge, M. V. C, Barbosa, A. M. P, Sobrevia, L, Gelaleti, R. B, Hallur, R. L. S, Marcondes, J. P. C, et al. Altered maternal metabolism during mild gestational hyperglycemia as a predictor of adverse perinatal outcomes: A comprehensive analysis. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 2020; 1866(2), 165478.
Simeonova-Krstevska, S, Bogoev, M, Bogoeva, K, Zisovska, E, Samardziski, I, Velkoska-Nakova, V, et al. Maternal and neonatal outcomes in pregnant women with gestational diabetes mellitus treated with diet, metformin or insulin. Open access Macedonian journal of medical sciences, 2018; 6(5), 803.
American Diabetes Association. 15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2021. Diabetes Care, 44(Supplement 1), 2021; S211-S220.
da Silva, J. R, Borges, P. S, Agra, K. F, Pontes, I. A, & Alves, J. G. B. Effects of an aquatic physical exercise program on glycemic control and perinatal outcomes of gestational diabetes: study protocol for a randomized controlled trial. Trials, 2013; 14(1), 1-5.
Najafian M, Mojgan B, Sara M, Ailin F, Zeinab S, Investigation the Effects of Metformin versus Insulin on Neonatal and Maternal Outcomes in Women with Gestational Diabetes Mellitus: A Randomized Clinical Trail , Global Journal of Health Science; Vol. 9, No. 4; 2017 ISSN 1916-9736 E-ISSN 19169744 Published by Canadian Center of Science and Education.
Priya G, Kalra, S. Metformin in the management of diabetes during pregnancy and lactation. Drugs in context, 2018; 7.
Ainuddin J, Karim N, Hasan AA, Naqvi SA. Metformin versus insulin treatment in gestational diabetes in pregnancy in a developing country. A randomized control trial. Diabetes research and clinical practice 2015; 107(2):290-9.
Iftakhar R. Benefit of metformin in reducing weight gain and insulin requirements in pregnancies complicated by gestational diabetes. Diabesity in Practice 2012; 3: 108–13.
Moosazadeh M, Asemi Z, Lankarani KB, Tabrizi R, Maharlouei N, Naghibzadeh-Tahami A, ET AL. Family history of diabetes and the risk of gestational diabetes mellitus in Iran: A systematic review and meta-analysis. Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S99-S104. doi: 10.1016/j.dsx.2016.12.016. Epub 2016 Dec 13. PMID: 28017634.
Yu, DQ, Xu, GX, Teng, XY. Glycemic control and neonatal outcomes in women with gestational diabetes mellitus treated using glyburide, metformin, or insulin: a pairwise and network metaanalysis. BMC Endocr Disord 21, 199 (2021). https://doi.org/10.1186/s12902-021-00865-9.
Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med. 2004;21(2):103–13. https://doi.org/10.1046/j.14645491.2003.00985.x.
Mukhopadhyay P, Bag TS, Kyal A, Saha DP, Khalid N. Oral hypoglycemic glibenclamide: can it be a substitute to insulin in the management of gestational diabetes mellitus? A comparative study. Journal of SAFOG. 2012; 4(1): 28–31. https://doi.org/10.5005/jpjournals-10006-1167.
Abbas M, Sinaa H, Haitham A. Effect of Metformin Versus Insulin on Maternal Weight Gain, in Women with Gestational Diabetes Mellitus: A Randomized Controlled Clinical Trial, DOI:10.21608/ebwhj.2021.51653.1117.
Bansal N, Priyanka C, Monika R, Namrata S. Comparison of metformin and insulin in the treatment of gestational diabetes: a retrospective study. Int J Reprod Contracept Obstet Gynecol 2016; 5(12):4356-4360.
Waheed S, Farhat PM, Syeda BM. Efficacy of Metformin Versus Insulin in the Management of Pregnancy with Diabetes. Journal of the College of Physicians and Surgeons Pakistan 2013; 23 (12): 866869.
Balsells, M, García-Patterson, A, Solà, I, Roqué, M, Gich, I, & Corcoy, R. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and metaanalysis. Bmj, 2015; 350.
Mesdaghinia E, Samimi M, Homaei Z, Saberi F, Moosavi SG, Yaribakht M. Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: a randomised blinded trial. Int J Prev Med. 2013; 4(3):327‐333.
Hayer SL, Rodin DA, Shehata H. Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study. Diabet Med 2009; 26: 798-802.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
